Search research articles
Contact Us
Filters
Showing results (111-120 of 124) with videos related to
Page
of 13
Sort By:
British Journal of Cancer
|
November 26, 2022
Dual [<sup>68</sup>Ga]DOTATATE and [<sup>18</sup>F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score
David L Chan, Aimee R Hayes, Ioannis Karfis, et al.
BMC Cancer
|
February 21, 2020
Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy
Ligia Craciun, Roland de Wind, Pieter Demetter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2024
Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial
Mattia Rediti, Danai Fimereli, Magdalena Mileva, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 5, 2013
18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO
Geraldine Gebhart, Cristina Gámez, Eileen Holmes, et al.
Oncotarget
|
May 1, 2018
Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor
Caroline Vandeputte, Pashalina Kehagias, Hakim El Housni, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 2, 2024
Prediction of <sup>177</sup>Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
Magdalena Mileva, Gwennaëlle Marin, Hugo Levillain, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 22, 2010
The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer
Philippe Lambin, Steven F Petit, Hugo J W L Aerts, et al.
Plos One
|
October 1, 2015
The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer
Alain Hendlisz, Amelie Deleporte, Thierry Delaunoit, et al.
Clinical Colorectal Cancer
|
August 18, 2021
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial
Caroline Vandeputte, Giacomo Bregni, Paraskevas Gkolfakis, et al.
The European Respiratory Journal
|
September 26, 2015
Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data
Marianne Paesmans, Camilo Garcia, Ching-Yee Oliver Wong, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 124) with videos related to
Sort By:
Page
of 13
British Journal of Cancer
|
November 26, 2022
Dual [<sup>68</sup>Ga]DOTATATE and [<sup>18</sup>F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score
David L Chan, Aimee R Hayes, Ioannis Karfis, et al.
BMC Cancer
|
February 21, 2020
Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy
Ligia Craciun, Roland de Wind, Pieter Demetter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2024
Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial
Mattia Rediti, Danai Fimereli, Magdalena Mileva, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 5, 2013
18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO
Geraldine Gebhart, Cristina Gámez, Eileen Holmes, et al.
Oncotarget
|
May 1, 2018
Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor
Caroline Vandeputte, Pashalina Kehagias, Hakim El Housni, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 2, 2024
Prediction of <sup>177</sup>Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
Magdalena Mileva, Gwennaëlle Marin, Hugo Levillain, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 22, 2010
The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer
Philippe Lambin, Steven F Petit, Hugo J W L Aerts, et al.
Plos One
|
October 1, 2015
The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer
Alain Hendlisz, Amelie Deleporte, Thierry Delaunoit, et al.
Clinical Colorectal Cancer
|
August 18, 2021
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial
Caroline Vandeputte, Giacomo Bregni, Paraskevas Gkolfakis, et al.
The European Respiratory Journal
|
September 26, 2015
Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data
Marianne Paesmans, Camilo Garcia, Ching-Yee Oliver Wong, et al.
Page
of 13